S T A T E O F N E W Y O R K
________________________________________________________________________
4054
2025-2026 Regular Sessions
I N A S S E M B L Y
January 31, 2025
___________
Introduced by M. of A. K. BROWN -- read once and referred to the Commit-
tee on Economic Development
AN ACT to amend the alcoholic beverage control law and the cannabis law,
in relation to requiring certain businesses in which alcohol or canna-
bis is consumed to have opioid antagonists
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Section 106 of the alcoholic beverage control law is
amended by adding a new subdivision 18 to read as follows:
18. ALL RETAIL LICENSEES FOR ON-PREMISES CONSUMPTION SHALL CONTAIN AN
OPIOID ANTAGONIST TO BE ADMINISTERED TO PATRONS, STAFF OR INDIVIDUALS ON
PREMISES OF SUCH ESTABLISHMENT. FOR THE PURPOSES OF THIS SUBDIVISION,
"OPIOID ANTAGONIST" MEANS NALOXONE, NARCAN OR ANY OTHER MEDICATION
APPROVED BY THE DEPARTMENT OF HEALTH AND THE FEDERAL FOOD AND DRUG
ADMINISTRATION THAT, WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE
OR IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN THE HUMAN BODY.
§ 2. Section 77 of the cannabis law is amended by adding a new subdi-
vision 15 to read as follows:
15. EACH ADULT-USE ON-SITE CONSUMPTION LICENSEE SHALL CONTAIN AN
OPIOID ANTAGONIST TO BE ADMINISTERED TO PATRONS, STAFF OR INDIVIDUALS ON
PREMISES OF SUCH ESTABLISHMENT. FOR THE PURPOSES OF THIS SUBDIVISION,
"OPIOID ANTAGONIST" MEANS NALOXONE, NARCAN OR ANY OTHER MEDICATION
APPROVED BY THE DEPARTMENT OF HEALTH AND THE FEDERAL FOOD AND DRUG
ADMINISTRATION THAT, WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE
OR IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN THE HUMAN BODY.
§ 3. This act shall take effect on the ninetieth day after it shall
have become a law.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD06280-01-5